Comparative Prognostic Performance of CARWL and Naples Prognostic Score in Stage IIIC Non-Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy
Medical Sciences · 12.06.2026 · 14 (2) · 310
DOI: 10.3390/medsci14020310 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Medical Sciences, online erschienen am 12.06.2026. Verfasst von Erkan Topkan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Faculty of Medical, Baskent University, Adana 01120, Turkey. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Chemoradiotherapy, Lung Neoplasms. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Prognostic stratification remains challenging in patients with stage IIIC non-small cell lung cancer (NSCLC) treated with definitive chemoradiotherapy (CCRT), and the relative performance of host-related prognostic indices in this setting is unclear. The CARWL (C-reactive Protein, Albumin, and Recent Weight Loss) score and the Naples prognostic score (NPS) have each been proposed as prognostic tools, but direct comparisons are lacking. This study compared their prognostic performance.
Methods
We retrospectively analyzed 795 patients with stage IIIC NSCLC treated with CCRT between 2010 and 2020. Patients were stratified into three prognostic groups according to CARWL and NPS. Overall survival (OS) was the primary endpoint; progression-free survival (PFS) and locoregional PFS (LRPFS) were secondary endpoints. Survival was assessed using Kaplan–Meier analysis and Cox regression.
Results
Both CARWL and NPS significantly stratified OS, PFS, and LRPFS (all p < 0.001). CARWL demonstrated modestly higher discriminatory performance across endpoints. The OS difference between unfavorable and favorable groups was larger with CARWL than with NPS (19.3 vs. 12.3 months). CARWL also provided greater separation for PFS (5.3 vs. 3.2 months) and LRPFS (4.9 vs. 3.4 months). In multivariable analyses, both indices retained independent prognostic significance; however, CARWL consistently exhibited stronger hazard gradients and maintained prognostic value when modeled alongside NPS.
Conclusions
Both CARWL and NPS offered meaningful prognostic stratification in stage IIIC NSCLC treated with CCRT, but CARWL demonstrated a modest but more consistent prognostic discrimination than NPS. Pending external validation, CARWL represents a practical and biologically grounded tool for risk stratification in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Faculty of Medical, Baskent University, Adana 01120, Turkey.
- Department of Radiation Oncology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar 03030, Turkey.
- Department of Radiation Oncology, School of Medicine, Koc University, Istanbul 34010, Turkey.
ORCID-Profile: Erkan Topkan, Ugur Selek
Zitieren
APA
Topkan, E., Ozturk, D., & Selek, U. (2026). Comparative Prognostic Performance of CARWL and Naples Prognostic Score in Stage IIIC Non-Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy. Medical Sciences, 14(2), 310. https://doi.org/10.3390/medsci14020310
Vancouver
Topkan E, Ozturk D, Selek U. Comparative Prognostic Performance of CARWL and Naples Prognostic Score in Stage IIIC Non-Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy. Medical Sciences. 2026;14(2):310. doi:10.3390/medsci14020310
BibTeX
@article{Topkan2026,
author = {Topkan, Erkan and Ozturk, Duriye and Selek, Ugur},
title = {Comparative Prognostic Performance of CARWL and Naples Prognostic Score in Stage IIIC Non-Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {2},
pages = {310},
doi = {10.3390/medsci14020310}
}
EUVIMED